First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis.

Hess, Lisa M; DeLozier, Amy M; Natanegara, Fanni; Wang, Xiaofei; Soldatenkova, Victoria; Brnabic, Alan; Able, Stephen L; Brown, Jacqueline

Hess, Lisa M; DeLozier, Amy M; Natanegara, Fanni; Wang, Xiaofei; Soldatenkova, Victoria; Brnabic, Alan; Able, Stephen L; Brown, Jacqueline.

Afiliação

Hess LM; Eli Lilly and Company, Indianapolis, Indiana, USA.
DeLozier AM; Eli Lilly and Company, Indianapolis, Indiana, USA.
Natanegara F; Eli Lilly and Company, Indianapolis, Indiana, USA.
Wang X; Eli Lilly and Company, Indianapolis, Indiana, USA.
Soldatenkova V; Lilly Deutschland GmbH, Bad Homburg, Germany.
Brnabic A; Eli Lilly and Company, West Ryde, NSW, Australia.
Able SL; Eli Lilly and Company, Indianapolis, Indiana, USA.
Brown J; Eli Lilly and Company, Windlesham, Surrey, UK.

J Thorac Dis ; 10(12): 6677-6694, 2018 Dec.

Article em En | MEDLINE | ID: mdl-30746213

Palavras-chave

Non-small cell lung cancer (NSCLC); S-1; chemotherapy; necitumumab; network meta-analysis; squamous

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google